Definitive Healthcare Corp. - Class A Common Stock (DH)

NIQ’s stock trades far below its IPO price, yet Advent is doubling down with a $2.35 billion position. For investors who want to understand whether this reflects hidden strength or leveraged risk, the details tell a deeper story.

Definitive Healthcare (DH) Q3 earnings beat profit estimates by 23%, sending shares up 7.5%. Revenue slightly missed, but strong cash flow and improved margins impressed investors.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.

DH stock results show that Definitive Healthcare met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!